Research Portal

What's the Beef with: Cronos Group stock analysis


Cronos Group Inc. (CRON)

Cannabis stocks and the Cronos Group in particular have been “blazing” trails since day one as this investment firm became the first to list on any major U.S exchange. The Cronos Group Inc. seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana primarily for Canada’s Medical Purposes Regulations.

Looking at the performance of some Cannabis stocks over the last 12 months it is noticeable from looking at ETFMG Alternative Harvest ETF (MJ) (blue line) that the stocks gained momentum late last year and are starting to move lower.

Click logo to view ETFMG Alternative Harvest ETF
New call-to-action

Take note, that the cannabis market is really in its infancy and this move lower might be the start of a (seasonal) trend forming, the same as which we find in commodity stocks.

Source - Bloomberg

Earnings and Outlook

The recent Q4 earnings released late March 2019 which did not exceed analysts’ expectations and was not completely unexpected. The firm still managed net revenue of over $15 million for the year and a gross profit of $8 million.

Despite the lack lustre earnings, recent investments and joint ventures will continue to make the Cronos Group an attractive company to invest in over the long term. From looking at the NASDAQ chart below we can see how Cronos (green line) stacked up against the NASDAQ index (blue line). The NASDAQ has gained 20.68% year to date, while Cronos gained over 50% over the same period.

Source - CNN Business

Chart life

Looking at the technical chart of The Cronos Group Inc. (CRON) we can see the price action broke out of the base at $13.93 per share and gained momentum. The price action is moving lower from its highs back toward the base, which is now support. The price needs to move higher which might give us an opportunity to invest above $19.39 per share. Our target price might possibly be back to the highs around $23.76 per share.

Source - Bloomberg

Portfolio particulars:

  • Portfolio Hold (Current).
  • Portfolio Buy opportunity above $19.39 (Future).
  • #WhatsTheBeef portfolio target price: $420 (just kidding), $23.76 (Future)

Know your company: Cronos Group Inc. (CRON)

  • The Cronos Group was the first cannabis company to list to a major U.S exchange and currently trades on the NASDAQ as well as Canada’s TSX Venture exchange.
  • Altria Group Inc. (MO) made Cronos Group its exclusive partner and bought a 45% equity stake worth close to $1.8 Billion.

Click logo to view Cronos
New call-to-action

 Follow Barry Dumas

Barry image

Barry is a market analyst with GT247, with a wealth of experience in the investment markets. Now in his tenth year in the markets, Barry "The Beef" Dumas brings a combination of technical analysis and fundamental insights to the table

Any opinions, news, research, reports, analyses, prices, or other information contained within this research is provided by Barry Dumas, Market Analyst at GT247 (Pty) Ltd t/a (“”) as general market commentary, and does not constitute investment advice for the purposes of the Financial Advisory and Intermediary Services Act, 2002. First World Trader (Pty) Ltd t/a EasyEquities (“EasyEquities”) and do not warrant the correctness, accuracy, timeliness, reliability or completeness of any information received from third party data providers. You must rely solely upon your own judgment in all aspects of your investment and/or trading decisions and all investments and/or trades are made at your own risk. EasyEquities and (including any of their employees) will not accept any liability for any direct or indirect loss or damage, including without limitation, any loss of profit, which may arise directly or indirectly from use of or reliance on the market commentary. The content contained within is subject to change at any time without notice.